March 2025

Huntsville gene experts at HudsonAlpha Institute for Biotechnology help launch clinical trial for new arthritis treatment

A five-year-long effort to better treat certain chronic diseases is entering a clinical trial in Europe, aided by Huntsville-based gene researchers. The European Union-funded research into immune-mediated inflammatory diseases involves experts from the public and private sectors, including the HudsonAlpha

Huntsville gene experts at HudsonAlpha Institute for Biotechnology help launch clinical trial for new arthritis treatment Read More »

Scroll to Top